Origin matters: Differences in embryonic tissue origin and Wnt signaling determine the osteogenic potential and healing capacity of frontal and parietal calvarial bones

Abstract

Calvarial bones arise from two embryonic tissues, namely, the neural crest and the mesoderm. In this study we have addressed the important question of whether disparate embryonic tissue origins impart variable osteogenic potential and regenerative capacity to calvarial bones, as well as what the underlying molecular mechanism(s). Thus, by performing in vitro and in vivo studies, we have investigated whether differences exist between neural crest–derived frontal and paraxial mesodermal–derived parietal bone. Of interest, our data indicate that calvarial bone osteoblasts of neural crest origin have superior potential for osteogenic differentiation. Furthermore, neural crest–derived frontal bone displays a superior capacity to undergo osseous healing compared with calvarial bone of paraxial mesoderm origin. Our study identified both in vitro and in vivo enhanced endogenous canonical Wnt signaling in frontal bone compared with parietal bone. In addition, we demonstrate that constitutive activation of canonical Wnt signaling in paraxial mesodermal–derived parietal osteoblasts mimics the osteogenic potential of frontal osteoblasts, whereas knockdown of canonical Wnt signaling dramatically impairs the greater osteogenic potential of neural crest–derived frontal osteoblasts. Moreover, fibroblast growth factor 2 (FGF-2) treatment induces phosphorylation of GSK-3β and increases the nuclear levels of β-catenin in osteoblasts, suggesting that enhanced activation of Wnt signaling might be mediated by FGF. Taken together, our data provide compelling evidence that indeed embryonic tissue origin makes a difference and that active canonical Wnt signaling plays a major role in contributing to the superior intrinsic osteogenic potential and tissue regeneration observed in neural crest–derived frontal bone. © 2010 American Society for Bone and Mineral Research

Shown for reading. Its publisher allows quoting it, not republishing it.

References 69

1. 1.

   Morriss-Kay GM. Derivation of the mammalian skull vault. J Anat. 2001;199:143-151.

   Not in our library10.1046/j.1469-7580.2001.19910143.x

2. 2.

   Jiang X, Iseki S, Maxson RE, Sucov HM, Morriss-Kay GM. Tissue origins and interactions in the mammalian skull vault. Dev Biol. 2002;241:106-116.

   Not in our library10.1006/dbio.2001.0487

3. 3.

   Chai Y, Jiang X, Ito Y, et al. Fate of the mammalian cranial neural crest during tooth and mandibular morphogenesis. Development. 2000;127:1671-1679.

   Not in our library10.1242/dev.127.8.1671

4. 4.

   LaBonne C, Bronner-Fraser M. Molecular mechanisms of neural crest formation. Annu Rev Cell Dev Biol. 1999;15:81-112.

   Not in our library10.1146/annurev.cellbio.15.1.81

5. 5.

   Anderson DJ. Genes, lineages and the neural crest: a speculative review. Philos Trans R Soc Lond B Biol Sci. 2000;355:953-964.

   Not in our library10.1098/rstb.2000.0631

6. 6.

   Trainor P, Krumlauf R. Development. Riding the crest of the Wnt signaling wave. Science. 2002;297:781-783.

   Not in our library10.1126/science.1075454

7. 7.

   Le Douarin NM, Calloni GW, Dupin E. The stem cells of the neural crest. Cell Cycle. 2008;7:1013-1019.

   Not in our library10.4161/cc.7.8.5641

8. 8.

   Couly G, Grapin-Botton A, Coltey P, Le Douarin NM. The regeneration of the cephalic neural crest, a problem revisited: the regenerating cells originate from the contralateral or from the anterior and posterior neural fold. Development. 1996;122:3393-3407.

   Not in our library10.1242/dev.122.11.3393

9. 9.

   Kontges G, Lumsden A. Rhombencephalic neural crest segmentation is preserved throughout craniofacial ontogeny. Development. 1996;122:3229-3242.

   Not in our library10.1242/dev.122.10.3229

10. 10.

    Karsenty G. Minireview: transcriptional control of osteoblast differentiation. Endocrinology. 2001;142:2731-2733.

    Not in our library10.1210/endo.142.7.8306

11. 11.

    Karsenty G, Wagner EF. Reaching a genetic and molecular understanding of skeletal development. Dev Cell. 2002;2:389-406.

    Not in our library10.1016/s1534-5807(02)00157-0

12. 12.

    Boulet AM, Moon AM, Arenkiel BR, Capecchi MR. The roles of Fgf4 and Fgf8 in limb bud initiation and outgrowth. Dev Biol. 2004;273:361-372.

    Not in our library10.1016/j.ydbio.2004.06.012

13. 13.

    Karsenty G. Transcriptional control of skeletogenesis. Annu Rev Genomics Hum Genet. 2008;9:183-196.

    Not in our library10.1146/annurev.genom.9.081307.164437

14. 14.

    Logan CY, Nusse R. The Wnt signaling pathway in development and disease. Annu Rev Cell Dev Biol. 2004;20:781-810.

    Not in our library10.1146/annurev.cellbio.20.010403.113126

15. 15.

    Nusse R. Wnt signaling in disease and in development. Cell Res. 2005;15:28-32.

    Not in our library10.1038/sj.cr.7290260

16. 16.

    Clevers H. Wnt/β-catenin signaling in development and disease. Cell. 2006;127:469-480.

    Not in our library10.1016/j.cell.2006.10.018

17. 17.

    Hartmann C. A Wnt canon orchestrating osteoblastogenesis. Trends Cell Biol. 2006;16:151-158.

    Not in our library10.1016/j.tcb.2006.01.001

18. 18.

    Krishnan V, Bryant HU, Macdougald OA. Regulation of bone mass by Wnt signaling. J Clin Invest. 2006;116:1202-1209.

    Not in our library10.1172/jci28551

19. 19.

    Nelson WJ, Nusse R. Convergence of Wnt, β-catenin, and cadherin pathways. Science. 2004;303:1483-1487.

    Not in our library10.1126/science.1094291

20. 20.

    Moon RT, Bowerman B, Boutros M, Perrimon N. The promise and perils of Wnt signaling through β-catenin. Science. 2002;296:1644-1646.

    Not in our library10.1126/science.1071549

21. 21.

    Lee JS, Ishimoto A, Yanagawa S. Characterization of mouse dishevelled (Dvl) proteins in Wnt/Wingless signaling pathway. J Biol Chem. 1999;274:21464-21470.

    Not in our library10.1074/jbc.274.30.21464

22. 22.

    Seto ES, Bellen HJ. The ins and outs of Wingless signaling. Trends Cell Biol. 2004;14:45-53.

    Not in our library10.1016/j.tcb.2003.11.004

23. 23.

    Ikeda S, Kishida S, Yamamoto H, Murai H, Koyama S, Kikuchi A. Axin, a negative regulator of the Wnt signaling pathway, forms a complex with GSK-3β and β-catenin and promotes GSK-3β-dependent phosphorylation of β-catenin. EMBO J. 1998;17:1371-1384.

    Not in our library10.1093/emboj/17.5.1371

24. 24.

    Akiyama T. Wnt/β-catenin signaling. Cytokine Growth Factor Rev. 2000;11:273-282.

    Not in our library10.1016/s1359-6101(00)00011-3

25. 25.

    He TC, Sparks AB, Rago C, et al. Identification of c-MYC as a target of the APC pathway. Science. 1998;281:1509-1512.

    Not in our library10.1126/science.281.5382.1509

26. 26.

    Tetsu O, McCormick F. β-Catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature. 1999;398:422-426.

    Not in our library10.1038/18884

27. 27.

    Jho EH, Zhang T, Domon C, Joo CK, Freund JN, Costantini F. Wnt/β-catenin/Tcf signaling induces the transcription of Axin2, a negative regulator of the signaling pathway. Mol Cell Biol. 2002;22:1172-1183.

    Not in our library10.1128/mcb.22.4.1172-1183.2002

28. 28.

    Hill TP, Spater D, Taketo MM, Birchmeier W, Hartmann C. Canonical Wnt/β-catenin signaling prevents osteoblasts from differentiating into chondrocytes. Dev Cell. 2005;8:727-738.

    Not in our library10.1016/j.devcel.2005.02.013

29. 29.

    Day TF, Guo X, Garrett-Beal L, Yang Y. Wnt/β-catenin signaling in mesenchymal progenitors controls osteoblast and chondrocyte differentiation during vertebrate skeletogenesis. Dev Cell. 2005;8:739-750.

    Not in our library10.1016/j.devcel.2005.03.016

30. 30.

    Gong Y, Slee RB, Fukai N, et al. LDL receptor-related protein 5 (LRP5) affects bone accrual and eye development. Cell. 2001;107:513-523.

    Not in our library10.1016/s0092-8674(01)00571-2

31. 31.

    Westendorf JJ, Kahler RA, Schroeder TM. Wnt signaling in osteoblasts and bone diseases. Gene. 2004;341:19-39.

    Not in our library10.1016/j.gene.2004.06.044

32. 32.

    Glass DA, Bialek P, Ahn JD, et al. Canonical Wnt signaling in differentiated osteoblasts controls osteoclast differentiation. Dev Cell. 2005;8:751-764.

    Not in our library10.1016/j.devcel.2005.02.017

33. 33.

    Boyden LM, Mao J, Belsky J, et al. High bone density due to a mutation in LDL-receptor-related protein 5. N Engl J Med. 2002;346:1513-1521.

    Not in our library10.1056/nejmoa013444

34. 34.

    Babij P, Zhao W, Small C, et al. High bone mass in mice expressing a mutant LRP5 gene. J Bone Miner Res. 2003;18:960-974.

    Not in our library10.1359/jbmr.2003.18.6.960

35. 35.

    Little RD, Carulli JP, Del Mastro RG, et al. A mutation in the LDL receptor-related protein 5 gene results in the autosomal dominant high-bone-mass trait. Am J Hum Genet. 2002;70:11-19.

    Not in our library10.1086/338450

36. 36.

    Holmen SL, Giambernardi TA, Zylstra CR, et al. Decreased BMD and limb deformities in mice carrying mutations in both Lrp5 and Lrp6. J Bone Miner Res. 2004;19:2033-2040.

    Not in our library10.1359/jbmr.040907

37. 37.

    Kato M, Patel MS, Levasseur R, et al. Cbfa1-independent decrease in osteoblast proliferation, osteopenia, and persistent embryonic eye vascularization in mice deficient in Lrp5, a Wnt coreceptor. J Cell Biol. 2002;157:303-314.

    Not in our library10.1083/jcb.200201089

38. 38.

    Chung BD, Kayserili H, Ai M, et al. A mutation in the signal sequence of LRP5 in a family with an osteoporosis-pseudoglioma syndrome (OPPG)-like phenotype indicates a novel disease mechanism for trinucleotide repeats. Hum Mutat. 2009.

    Not in our library10.1002/humu.20916

39. 39.

    Takada S, Stark KL, Shea MJ, Vassileva G, McMahon JA, McMahon AP. Wnt-3a regulates somite and tailbud formation in the mouse embryo. Genes Dev. 1994;8:174-189.

    Not in our library10.1101/gad.8.2.174

40. 40.

    Ikeya M, Takada S. Wnt-3a is required for somite specification along the anteroposterior axis of the mouse embryo and for regulation of cdx-1 expression. Mech Dev. 2001;103:27-33.

    Not in our library10.1016/s0925-4773(01)00338-0

Cited by papers we hold 4

• Regulation and Role of Transcription Factors in Osteogenesis · 2021
  No notice
• Making and shaping endochondral and intramembranous bones · 2020
  No notice
• Functional Relationship between Osteogenesis and Angiogenesis in Tissue Regeneration · 2020
  No notice
• Animal models for bone tissue engineering and modelling disease · 2018
  No notice

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.